Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Honghui Zhou

Showing results (111-120 of 143) with videos related to

Pageof 15
Sort By:
Journal of Clinical Pharmacology|November 27, 2009
Subcutaneous bioavailability of golimumab at 3 different injection sites in healthy subjectsZhenhua Xu, Qingmin Wang, Yanli Zhuang, et al.
Current Drug Metabolism|April 6, 2012
De-risking bio-therapeutics for possible drug interactions using cryopreserved human hepatocytesShannon Dallas, Carlo Sensenhauser, Ameesha Batheja, et al.
Journal of Clinical Pharmacology|July 21, 2009
Population pharmacokinetics of golimumab, an anti-tumor necrosis factor-alpha human monoclonal antibody, in patients with psoriatic arthritisZhenhua Xu, Thuy Vu, Howard Lee, et al.
Clinical Drug Investigation|August 27, 2013
Pharmacokinetics and safety of golimumab in healthy Chinese subjects following a single subcutaneous administration in a randomized phase I trialYanli Zhuang, Sally Lyn, Yuan Lv, et al.
Clinical Therapeutics|December 16, 2011
Golimumab pharmacokinetics after repeated subcutaneous and intravenous administrations in patients with rheumatoid arthritis and the effect of concomitant methotrexate: an open-label, randomized studyYanli Zhuang, Zhenhua Xu, Bart Frederick, et al.
Prenatal Diagnosis|July 27, 2018
Noninvasive prenatal test for FGFR3-related skeletal dysplasia based on next-generation sequencing and plasma cell-free DNA: Test performance analysis and feasibility explorationYuan Ren, Jia Zhao, Ruibing Li, et al.
The AAPS Journal|November 28, 2013
A novel approach to evaluate the pharmacokinetic biocomparability of a monoclonal antibody derived from two different cell lines using simultaneous crossover designChao Han, Thomas S McIntosh, Brian J Geist, et al.
Gastroenterology|September 1, 2014
Association between serum concentration of infliximab and efficacy in adult patients with ulcerative colitisOmoniyi J Adedokun, William J Sandborn, Brian G Feagan, et al.
Clinical Pharmacology in Drug Development|April 30, 2016
A phase 1, randomized study to assess the pharmacokinetic comparability of siltuximab derived from two different cell lines in healthy subjectsChao Xu, Chao Han, Joseph Marini, et al.
Clinical Pharmacokinetics|November 30, 2016
Pharmacokinetics of Daratumumab Following Intravenous Infusion in Relapsed or Refractory Multiple Myeloma After Prior Proteasome Inhibitor and Immunomodulatory Drug TreatmentPamela L Clemens, Xiaoyu Yan, Henk M Lokhorst, et al.
Pageof 15

Showing results (111-120 of 143) with videos related to

Sort By:
Pageof 15
Journal of Clinical Pharmacology|November 27, 2009
Subcutaneous bioavailability of golimumab at 3 different injection sites in healthy subjectsZhenhua Xu, Qingmin Wang, Yanli Zhuang, et al.
Current Drug Metabolism|April 6, 2012
De-risking bio-therapeutics for possible drug interactions using cryopreserved human hepatocytesShannon Dallas, Carlo Sensenhauser, Ameesha Batheja, et al.
Journal of Clinical Pharmacology|July 21, 2009
Population pharmacokinetics of golimumab, an anti-tumor necrosis factor-alpha human monoclonal antibody, in patients with psoriatic arthritisZhenhua Xu, Thuy Vu, Howard Lee, et al.
Clinical Drug Investigation|August 27, 2013
Pharmacokinetics and safety of golimumab in healthy Chinese subjects following a single subcutaneous administration in a randomized phase I trialYanli Zhuang, Sally Lyn, Yuan Lv, et al.
Clinical Therapeutics|December 16, 2011
Golimumab pharmacokinetics after repeated subcutaneous and intravenous administrations in patients with rheumatoid arthritis and the effect of concomitant methotrexate: an open-label, randomized studyYanli Zhuang, Zhenhua Xu, Bart Frederick, et al.
Prenatal Diagnosis|July 27, 2018
Noninvasive prenatal test for FGFR3-related skeletal dysplasia based on next-generation sequencing and plasma cell-free DNA: Test performance analysis and feasibility explorationYuan Ren, Jia Zhao, Ruibing Li, et al.
The AAPS Journal|November 28, 2013
A novel approach to evaluate the pharmacokinetic biocomparability of a monoclonal antibody derived from two different cell lines using simultaneous crossover designChao Han, Thomas S McIntosh, Brian J Geist, et al.
Gastroenterology|September 1, 2014
Association between serum concentration of infliximab and efficacy in adult patients with ulcerative colitisOmoniyi J Adedokun, William J Sandborn, Brian G Feagan, et al.
Clinical Pharmacology in Drug Development|April 30, 2016
A phase 1, randomized study to assess the pharmacokinetic comparability of siltuximab derived from two different cell lines in healthy subjectsChao Xu, Chao Han, Joseph Marini, et al.
Clinical Pharmacokinetics|November 30, 2016
Pharmacokinetics of Daratumumab Following Intravenous Infusion in Relapsed or Refractory Multiple Myeloma After Prior Proteasome Inhibitor and Immunomodulatory Drug TreatmentPamela L Clemens, Xiaoyu Yan, Henk M Lokhorst, et al.
Pageof 15